26750 Cumulative clinical benefits of biologic treatments for psoriasis over 1 year

Andrew Blauvelt; Melinda Gooderham; Christopher Em Griffiths; Baojin Zhu; Russel Burge; Gaia Gallo; Jiaying Guo; Alyssa Garrelts; Mark Lebwohl

doi:10.1016/j.jaad.2021.06.479

Back

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2022

Cumulative Clinical Benefits of Biologics in the Treatment of Patients with Moderate-to-Severe Psoriasis over 1 Year: a Network Meta-Analysis

Andrew Blauvelt, Melinda Gooderham, Christopher Em Griffiths, April W. Armstrong, Baojin Zhu, Russel Burge, Gaia Gallo, Jiaying Guo, Alyssa Garrelts, Mark Lebwohl

Article2016

024 Psoriasis Stratification to Optimise Relevant Therapy (PSORT): Clinical and demographic predictors of biologic response for psoriasis

Richard B. Warren, David Burden, Barbara Tomenson, Moetaza M. Soliman, Richard Emsley, Christopher Em Griffiths, Catherine Smith

Article2008

Topical Treatments for Scalp Psoriasis

Richard B. Warren, Benjamin Brown, Christopher Em Griffiths

Article2008

The use of biologic therapies for the treatment of moderate-to-severe psoriasis in UK clinical practice

Richard B. Warren, Benjamin Brown, D. Lavery, Darren M. Ashcroft, Christopher Em Griffiths

Article2001

Treatments for chronic palmoplantar pustular psoriasis.

Alexander Marsland, Christopher Em Griffiths